Healthcare Administrators & Facility Leadership

Better care has to work operationally, too.

Carebidet is an automated in-bed toileting system for appropriate bedbound individuals or those requiring significant assistance. For administrators, the question is broader than the technology: can it improve workflow, support staff, reduce recurring care burden and deliver measurable value in your facility?

  • Workflow efficiency
  • Staff satisfaction
  • Potential operating savings
  • Quality priorities

Observed Carebidet Results

Start with what has actually been measured.

Early Australian pilots reported meaningful reductions in caregiver time, consumables and manual handling. These limited observational findings are not guarantees of what every facility will experience, but they identify practical measures to test in a structured facility trial.

97%

Fewer wet wipes

Wet wipe use fell from 196 to 5 units per week by Week 3 in a 21-day Australian home care pilot.

96%

Fewer gloves

Glove use fell from 91 to 4 pairs per week in the same pilot.

100%

Reduction in disposable pads and linens

Use fell from 52 per week at baseline to zero by Week 3.

16.4 hrs

Caregiver time recovered

Across 115 automated cycles, the pilot recorded 986 minutes of caregiver time saved over 21 days.

Direct Economic Signal

AUD $2,963.40 in direct labor and consumable savings over 21 days

The report calculated an average weekly saving of AUD $987.80, driven primarily by caregiver time recovery and reduced disposable pad and linen use. The study involved one fully bedbound participant and should be viewed as hypothesis-generating rather than as a facility-wide forecast.

Published pilot report ↗
84% less weekly toileting care time Weekly toileting time fell from 880 to 140 minutes in the 21-day pilot.
55% fewer lifting and log-roll events Events fell from 40 to 18 per week, a useful measure of manual handling for facility evaluation.
No new pressure injury reported An 8-week Australian residential aged care pilot reported no pressure-injury development during the evaluation period.
Zero UTIs reported The same aged-care pilot reported no UTIs during the evaluation period. This was an observational finding and does not establish that Carebidet prevented UTIs.

Published Clinical Research

There is also a clinical signal worth evaluating.

A 2021 quasi-experimental ICU study compared Carebidet-assisted defecation care with standard wet-wipe cleansing in 55 critical care patients. The findings do not prove that Carebidet prevents pressure injuries, but they provide published clinical evidence related to incontinence-associated dermatitis and pressure injury risk.

55 ICU patients · 2021

The Carebidet group showed significantly different IAD and Braden score trajectories

The study reported significant group-by-time effects for incontinence-associated dermatitis and Braden pressure injury risk scores. The authors concluded that Carebidet-assisted care was associated with slower IAD progression and preserved skin integrity relative to standard manual care during the seven-day observation period.

What this means: The study supports further evaluation of Carebidet’s potential skin-related benefits, but it should not be interpreted as proof that Carebidet prevents hospital-acquired pressure injuries.

Caregiver acceptance

One-month field study of 30 Carebidet caregivers

A 2026 peer-reviewed study found positive service adequacy scores for core functional attributes including effectiveness, convenience and safety after four weeks of use.

View DOI →
Caregiver preferences

Professional caregivers valued automated waste management

A 2026 discrete choice study found strong preferences for combined urine/feces detection, automatic waste disposal, and washing and drying after defecation.

View DOI →
Looking for the full evidence base? Published studies, pilot reports, clinical research and supporting evidence.
Explore the Toileting Care Research Library

Why the Evidence May Matter

Carebidet changes several expensive parts of the care process.

The strongest current value proposition is not a promise of a specific outcome. It is a measurable change in how toileting and hygiene care are delivered, supported by published evidence that can help facilities evaluate whether those changes translate into better operational or clinical results.

Labor & workflow Automated detection, waste removal, washing and drying may reduce repeated hands-on hygiene care time and redirect staff time to other care priorities.
Consumables & laundry Published pilot data show large reductions in wipes, gloves, disposable pads and linens in one intensive home care setting.
Manual handling & falls For a Carebidet toileting episode, the individual remains in bed. That removes the bathroom transfer for that episode and may reduce associated handling burden.
Skin & moisture exposure Immediate waste removal followed by washing and drying limits prolonged contact with urine, feces and residual moisture. Published ICU research supports further evaluation of potential skin-related effects.
Evidence standard used on this page

Observed pilot results are presented as observed results. Peer-reviewed research is identified as research. Potential benefits are described as potential benefits. Carebidet is not represented here as proven to prevent pressure injuries, UTIs, mortality, litigation or reimbursement penalties.

Facility Impact Calculator

Now substitute your facility’s numbers.

The published pilots give us variables worth measuring: caregiver time, wipes, gloves, pads / linens, handling and other recurring care costs. Use your own assumptions here rather than applying the Australian results directly to your facility.

Current annual care process cost$0
Illustrative annual Carebidet process cost$0
Illustrative annual operating difference$0

This is an operational planning model, not a clinical outcome guarantee. Equipment acquisition, service, training and facility specific implementation costs should be added separately.

Keep clinical outcomes separate from base ROIFalls, skin outcomes, infection, liability and reimbursement exposure may be important to the evaluation, but they should not be counted as Carebidet savings unless facility-specific results or stronger evidence support that conclusion.

Measure It in Your Facility

Test the value before you scale it.

A controlled trial can determine whether Carebidet fits the population, staffing model and operating environment while generating the facility-specific data needed for an informed decision.

1Select a unitChoose a defined care setting and appropriate users.
2Establish baselineCapture time, supplies, handling, transfers and staff feedback.
3Train staffPlacement, operation, cleaning and disinfection.
4Run the pilotUse agreed criteria and document workflow and safety observations.
5Review valueCompare operational, staff, clinical observations and financial findings.

Facility Evaluation

Evaluate Carebidet with your facility’s own data.

We can help identify appropriate users, baseline measures, and a focused evaluation plan.